38
Participants
Start Date
August 3, 2018
Primary Completion Date
July 30, 2021
Study Completion Date
July 30, 2021
Roflumilast 500 Mcg Oral Tablet
The first two weeks the participant will take one tablet every other day. If well tolerated, participant will take one tablet every day.
Placebo oral capsule
The first two weeks the participant will take one tablet every other day. If well tolerated, participant will take one tablet every day.
Mount Sinai Icahn School of Medicine, New York
Duke University, Durham
University of Alabama Lung Health Center, Birmingham
University of Illinois at Chicago, Breathe Chicago Center, Chicago
Northwestern University Feinberg School of Medicine, Chicago
University of Arizona, Tucson
University of Vermont, Colchester
American Lung Association
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Johns Hopkins University
OTHER